VEGFA and colorectal carcinoma: We then examined S100B effects (2) on Akt/mTOR pathway and VEGF signaling in the presence or absence of specific monoclonal anti-S100B antibody, in order to confirm/exclude its specific involvement in CRC cells-related malignancy and angiogenesis.